Coronary artery disease Posts Page 4 on Medivizor
Navigation Menu

Coronary artery disease Posts on Medivizor

The effects of widening blood vessels on maximum blood flow to the heart in patients with coronary artery disease

Posted by on Feb 28, 2019 in Coronary artery disease | 0 comments

In a nutshell This study aimed to investigate the effects of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) on maximum blood flow in patients with coronary artery disease (CAD). The main finding of the study was that these procedures stopped the decrease in maximum blood flow through the heart arteries. Some...

Read More

How effective and cost-efficient is ranolazine compared to other anti-angina drugs?

Posted by on Feb 24, 2019 in Coronary artery disease | 0 comments

In a nutshell This study aimed to compare the effectiveness and cost of ranolazine compared to other anti-angina drugs. The main finding of the study was that ranolazine users had lower rates of coronary artery bypass grafting (CABG) and overall hospitalizations, but higher rates of percutaneous coronary intervention (PCI) and hospitalizations due to...

Read More

Long-term outcomes of 3 different drug-releasing heart stents

Posted by on Feb 16, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to compare the safety and effectiveness of 3 different drug-releasing stents for the heart blood vessels (biodegradable stents versus new permanent stents versus older permanent stents) after 10 years. The main finding of the study was that biodegradable and new permanent stents showed similar results and were...

Read More

Vitamin D deficiency and cardiovascular health: is there an increased risk of injury?

Posted by on Jan 31, 2019 in Coronary artery disease | 0 comments

In a nutshell This study investigated if vitamin D deficiency (VDD) is associated with subclinical myocardial injury (SC-MI) in patients with cardiovascular disease (CVD). They found that VDD is linked to SC-MI, particularly in men.  Some background Cardiovascular disease (CVD) can be caused by a number of factors. Poor diet is a risk factor...

Read More

Searching for patients with coronary artery disease to test a new medication

Posted by on Jan 27, 2019 in Coronary artery disease | 0 comments

In a nutshell This phase 3 trial will determine if bempedoic acid (BPDA) reduces the risk of cardiovascular events (CVEs) in statin-intolerant (ST-IT) patients. The main outcome will be the time taken for a CVE to occur. The details Cardiovascular disease (CVD) is a serious condition that can lead to serious events (CVEs). CVEs include heart...

Read More

Can a big first dose of atorvastatin lower poor outcomes in patients with heart attacks?

Posted by on Jan 27, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to investigate if a large first dose (loading dose) of atorvastatin (Lipitor) can reduce major adverse cardiovascular events (MACE) in patients with heart attacks and unstable angina. Some background Acute coronary syndrome (ACS) is a term which describes heart attacks and unstable angina A heart attack is a...

Read More

Diastolic blood pressure can predict the size of plaque in heart blood vessels

Posted by on Jan 13, 2019 in Coronary artery disease | 0 comments

In a nutshell The aim of this study was to investigate the relationship between blood pressure and plaque size in coronary (heart) blood vessels. The main finding of the study was that diastolic (the second number in the blood pressure reading) blood pressure can predict the size of the coronary plaque. Some background High blood pressure is a major...

Read More